A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

NCT00174785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4628

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Atrial Flutter

Interventions

DRUG: dronedarone (SR33589)
DRUG: placebo

Sponsor

Sanofi